arrow
返回
J

Jason J. Luke

UPMC Hillman Cancer Center and University of Pittsburgh

63H指数
808论文数
2.3W被引数
收录论文 136
发表时间
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years原发性黑色素瘤假阴性诊断患者的生命损失年数。一项涉及9063例患者、为期28年的德国中央恶性黑色素瘤登记研究的回顾性研究
err2026-07-02
err0
errOAAI
errClaus Garbe; Ulrike Keim; Teresa Amaral; Paolo A. Ascierto; Jürgen Bauer; Reinhard Dummer; Alexander M. M. Eggermont; Thomas K. Eigentler; Lukas Flatz; Stephan Forchhammer; Andrea Forschner; Sara Gandini; Jeffrey E. Gershenwald; Axel Hauschild; Christoph Hoeller; John M. Kirkwood; Celeste Lebbe; Georgina V. Long; Paul Lorigan; Jason J. Luke; Friedegund Meier; Gisela Metzler; Paul Nathan; Michael A. Postow; Caroline Robert; Martin Röcken; Dirk Schadendorf; Benjamin Weide; David Whiteman; Ulrike Leiter; Peter Martus
err分享
err收藏
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical Trials细胞因子释放症状而非综合征:呼吁在临床试验中详细报告细胞因子相关不良事件
err2026-04-02
err0
PREAI
errJ-D Fumet; M.Roulleaux Dugage; F-X Danlos; T. Hueso; D.J. Pinato; J. Luke; I. Melero Bermejo; P. Lorusso; J. Brody; K. Harrington; N.H. Segal; A. Diab; E. Gerralda Cabanas; T. Marron; R. Houot; S. Champiat; A. Marabelle
err分享
err收藏
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid TumorsI期b研究:达唑替尼加帕博利珠单抗在特定晚期实体瘤患者接受低分割放射治疗后的应用
err2025-12-01
err0
errOAAI
errCooper, Benjamin T.; Iams, Wade T.; Page, David B.; Yuan, Yuan; Gerber, Naamit K.; Luke, Jason J.; Gibbs, John P.; Gregory, Richard C.; Wong, Kwok-Kin; Deng, Jiehui; Perera, Samanthi A.; Ding, Kai; Roberts, Emily R.; Berger, Allison; Christensen, Camilla L.; Tong, Erica Xin; Maldonado Lopez, Angel E.; Appleman, Vicky A.; Leonard, E. Jane; Parent, Alexander; Huang, Yu-Chung; Bay, Camden; Li, Cong; Lineberry, Neil; Raizer, Jeffrey; Olson, Daniel J.; Chmura, Steven J.
err分享
err收藏
Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer整合人工智能驱动的数字病理学和基因组学,以建立基于患者来源的类器官作为头颈癌药物反应的新方法学。
err2025-11-09
err0
errOAAI
errRose Doerfler; Jie Chen; Carl Kim; Joshua D. Smith; Micah Harris; Krishna B. Singh; Brian Isett; Rebekah E. Dadey; Daniel D. Brown; Adrian V. Lee; Xuefeng Wang; Matthew E. Spector; Seungwon Kim; Shaum Sridharan; Kevin Contrera; Katelyn Smith; Carly Reeder; Maureen Lyons; Jianhua Luo; Silvia Liu; Dan P. Zandberg; Heath D. Skinner; Ioannis K. Zervantonakis; Lazar Vujanović; Robert L. Ferris; Raja R. Seethala; José P. Zevallos; Jason J. Luke; Riyue Bao
err分享
err收藏
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutationsNguyen, M.K.; Jelinek, M.; Singh, A.; Isett, B.; Myers, E.S.; Mullett, S.J.; Eisele, Y.; Beumer, J.; Parise, R.; Urban, J.; et al. 关于ivosidenib联合nivolumab治疗携带IDH1突变的晚期实体瘤的临床与转化研究。medRxiv 2025. [Google Scholar] [CrossRef]
err2025-11-01
err0
PREAI
errNguyen, Matthew K.; Jelinek, Mark; Singh, Arjun; Isett, Brian; Myers, Erica S.; Mullett, Steven J.; Eisele, Yvonne; Beumer, Jan H.; Parise, Robert A.; Urban, Julie; Rose, Amy; Sellitto, Lorenzo; Singh, Krishna; Doerfler, Rose; Dadey, Rebekah E.; Kim, Carl; Rhee, John C.; Davar, Diwakar; Villaruz, Liza C.; Burgess, Melissa; Drappatz, Jan; Mantica, Megan; Goodman, Amy E.; Wang, Hong; Singhi, Aatur D.; Luke, Jason J.; Zandberg, Dan P.; Bao, Riyue
err分享
err收藏
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)I期临床试验:评估ataxia telangiectasia和Rad3-related抑制剂berzosertib联合伊立替康治疗晚期实体瘤患者的疗效(ETCTN 9938)
errCancer
IF5.1
err2025-10-29
err0
PREAI
errLiza C. Villaruz MD; Jingxiao Jin MD; Hong Wang PhD; James J. Lee MD, PhD; Jason J. Luke MD; John C. Rhee MD; Saiama N. Waqar MD; Geoffrey I. Shapiro MD, PhD; James Cleary MD, PhD; Diwakar Davar MD; Timothy F. Burns MD, PhD; Rashmi Verma MD; Manik Amin MD; Leonard Appleman MD, PhD; Kristen K. Ciombor MD; Elizabeth J. Davis MD; Jonathan W. Riess MD; E. Claire Dees MD; Edward J. Kim MD, PhD; Dana Cardin MD; Jianxia Guo PhD; Susan M. Christner BS; Joshua Deppas MS; Angelina M. Parise BS; John C. Schmitz PhD; Bella S. Guerrouahen PhD; Michael Suchko BS; Alejandro Contreras MD, PhD; Li Li PhD; Katherine V. Ferry-Galow PhD; Ting-Chia Chang MS; Shahanawaz Jiwani MD, PhD; Christopher J. Bakkenist PhD; Edward Chu MD; Steven D. Gore MD; Jan H. Beumer PharmD, PhD
err分享
err收藏
Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial快速整合生物标志物计划在指导免疫肿瘤临床试验中的合理性与可行性:ADVISE试验
err2025-05-19
err0
errOAAI
errLuke, Jason J.; Bever, Katherine; Hodi, F. Stephen; Taube, Janis; Massey, Ashish; Yao, David; Neely, Jaclyn; Tam, Rachel; Lee, George; Gupta, Akshita; Dutta, Santanu; Szabo, Peter; Bao, Riyue; Reilly, Tim
err分享
err收藏
A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapySITC愿景:调整临床试验以加速癌症免疫疗法的药物开发
err2025-03-22
err0
errOAAI
errMarron, Thomas U.; Luke, Jason J.; Hoffner, Brianna; Perlmutter, Jane; Szczepanek, Connie; Anagnostou, Valsamo; Silk, Ann W.; Romero, Pedro J.; Garrett-Mayer, Elizabeth; Emens, Leisha A.
err分享
err收藏
Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 TrialPembrolizumab在II期黑色素瘤中的辅助治疗: 随机,双盲,III期KEYNOTE-716试验中原发性肿瘤位置的结果
err2025-02-01
err0
PREAI
errYoon, Charles H.; Ross, Merrick I.; Gastman, Brian R.; Luke, Jason J.; Ascierto, Paolo A.; Long, Georgina V.; Rutkowski, Piotr; Khattak, Muhammad; Del Vecchio, Michele; de la Cruz Merino, Luis; Mackiewicz, Jacek; Chiarion-Sileni, Vanna; Schadendorf, Dirk; Carlino, Matteo S.; Zhao, Yujie; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M. M.; Gershenwald, Jeffrey E.; Sondak, Vernon K.
err分享
err收藏
Jeffrey S Weber, MD, PhD (1952-2024): in memoriam to discovery, friendship and family
err2024-09-10
err0
errOAAI
errLuke, Jason John; Hamid, Omid; Fox, Bernard A.; Ascierto, Paolo A.; Osman, Iman; Mule, James J.; Romero, Pedro J.; Lotze, Michael T.
err分享
err收藏
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials联合消融放疗和免疫检查点抑制剂在三个I期试验中的安全性
err2024-09-01
err0
PREAI
errLynch, Connor; Korpics, Mark C.; Katipally, Rohan R.; Bestvina, Christine M.; Pitroda, Sean P.; Patel, Jyoti D.; Luke, Jason J.; Chmura, Steven J.; Juloori, Aditya
err分享
err收藏
A phase I, first-in-human, dose escalation and expansion study of oral pan-RAF/MEK molecular glue NST-628 in subjects with solid tumors harboring RAS-MAPK pathway alterations一项I期、首次人体、剂量递增和扩展研究,评估口服泛RAF/MEK分子胶NST-628在携带RAS-MAPK通路异常的实体瘤受试者中的效果。
err2024-09-01
err0
PREAI
errLemech, C.; Luke, J. J.; Falchook, G. S.; Mckean, M.; Kichenadasse, G.; Teng, C.; Vandross, A. L.; Salkeni, M. A.; Atkinson, V. G.; Liu, J. J.; Kennedy, A. M.; Clark, J.; Ryan, M.; Schmidt-Kittler, O.; Steinhubel, D.; Wages, D.; Komarnitsky, P.; Puzanov, I.
err分享
err收藏
Mechanisms of recurrence following mRNA-4157 (V940) plus pembrolizumab or pembrolizumab alone in resected melanoma from the mRNA-4157-P201 (KEYNOTE-942) trialmRNA-4157(V940)联合pembrolizumab或pembrolizumab单药治疗在切除的黑素瘤中复发的机制:来自mRNA-4157-P201(KEYNOTE-942)试验
err2024-09-01
err0
PREAI
errSullivan, R. J.; Lu, M.; Koppolu, S.; Weber, J. S.; Carlino, M. S.; Khattak, M. A.; Ansstas, G.; Taylor, M. H.; Mckean, M.; Long, G. V.; Faries, M. B.; Luke, J. J.; Sehgal, V.; Rao, A.; Mao, H.; Guo, J.; Brown, M.; Meehan, R.; Feldman, I.; Srinivasan, L.
err分享
err收藏
Pembrolizumab (pembro) vs placebo as adjuvant therapy for high-risk stage II melanoma: Long-term follow-up, rechallenge, and crossover in KEYNOTE-716帕博利珠单抗(pembro)对比安慰剂作为高危Ⅱ期黑色素瘤辅助治疗:长期随访、再挑战与交叉研究(KEYNOTE-716)
err2024-09-01
err2
PREAI
errLuke, J. J.; Ascierto, P. A.; Khattak, M. A.; Rutkowski, P.; Del Vecchio, M.; Spagnolo, F.; Mackiewicz, J.; de la Cruz Merino, L.; Sileni, V. Chiarion; Kirkwood, J. M.; Robert, C.; Schadendorf, D.; De Galitiis, F.; Carlino, M. S.; Odeleye-Ajakaye, A.; Kalabis, M.; Krepler, C.; Eggermont, A. M. M.; Long, G. V.
err分享
err收藏
Phase I/II trial of ASP1570, a novel diacylglycerol kinase z inhibitor, in patients with advanced solid tumorsI/II期ASP1570临床试验,ASP1570是一种新型二酰基甘油激酶z抑制剂,用于治疗晚期实体瘤患者
err2024-09-01
err0
PREAI
errOlson, D.; Dowlati, A.; Luke, J. J.; Mckean, M.; Yoshida, T.; Park, D.; Kitano, S.; Barve, M.; Kaneko, Y.; Koelsch, G.; Soukharev, S.; Takeshita, S.; Alsharif, N.; Hashemi, N.; Patel, M. R.
err分享
err收藏
First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumorsHST-1011(一种口服CBL-B抑制剂)在晚期实体瘤患者中的首次人体(FIH)I期数据
err2024-09-01
err0
PREAI
errSanborn, R. E.; Patel, M. R.; Rodon, J.; Thein, K. Z.; Friedman, C.; Levitz, D.; Ngirailemesang, I.; Goodman, A.; Agarwal, P.; Friedman, E.; Danaee, H.; Robell, K.; Jaeger, S.; Sun, H.; Debanne, E.; Dunn, J.; Wright, E.; Reilly, T.; Luke, J. J.; Redig, A.
err分享
err收藏
Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non - small cell lung cancer, and renal cell carcinoma
err2024-08-01
err0
errOAAI
errLuke, Jason J.; Long, Georgina V.; Robert, Caroline; Carlino, Matteo S.; Choueiri, Toni K.; Haas, Naomi B.; O'Brien, Mary; Paz-Ares, Luis; Peters, Solange; Powles, Thomas; Leiby, Melanie A.; Lin, Jianxin; Zhao, Yujie; Krepler, Clemens; Perini, Rodolfo F.; Pietanza, M. Catherine; Samkari, Ayman; Gruber, Todd; Ibrahim, Nageatte; Eggermont, Alexander M. M.
err分享
err收藏
The emergence of neoadjuvant immune-over BRAF therapy in melanoma
errCANCER
IF5.1
err2024-07-22
err0
PREAI
errRozeman, Elisa A.; Luke, Jason J.
err分享
err收藏
Top advances of the year: Melanoma
errCANCER
IF5.1
err2024-04-29
err0
PREAI
errKhattak, Muhammad Adnan; Luke, Jason J.
err分享
err收藏
US physician perspective on the use of biomarker and ctDNA testing in patients with melanoma
err2024-04-01
err0
errOAAI
errFischer, Rachel A.; Ryan, Isabel; Torre, Kristine De La; Barnett, Cody; Sehgal, Viren S.; Levy, Joan B.; Luke, Jason J.; Poklepovic, Andrew S.; Hurlbert, Marc S.
err分享
err收藏